All In Biotech

Drug Trial Radar · NCT05029635

Phase III Study on HMPL-523 for Treatment of ITP

A Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HMPL-523 in Treatment of Primary Immune Thrombocytopenia (ITP) in Adults (ESLIM-01 Study)

Last checked: Nov 19, 2026Latest source record: May 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 272 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

272

Actual

Start

Oct 27, 2021

Primary completion

May 16, 2025

Study completion Sep 18, 2025

Sponsor

Lead sponsor
HutchmedIndustry
Sponsor type
Industry
First posted
Aug 31, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether HMPL-523 (sovleplenib) is safe and effective in the treatment of chronic Immune Thrombocytopenic Purpura (ITP).

Conditions

  • Primary Immune Thrombocytopenia (ITP)

Interventions

  • HMPL-523Drug

    HMPL-523(300mg PO QD)

  • PlaceboDrug

    Placebo(300mg PO QD)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the durable response rate in the primary studyTime frame: treatment period Week14-Week24

Locations

37 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China

  • The First Affiliated hospital of USTC

    Hefei, Anhui, China

  • Beijing Chaoyang Hospital of Capital Medical University

    Beijing, Beijing Municipality, China

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China

  • People's Hospital of Peking University

    Beijing, Beijing Municipality, China

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, China

  • Lanzhou University Second Hospital

    Lanzhou, Gansu, China

  • Guangdong General Hospital

    Guangzhou, Guangdong, China

  • Southern Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • The Second People's Hospital Of Shenzhen

    Shenzhen, Guangdong, China

  • The First Affiliated Hospital Of GuangXi Medical University

    Nanning, Guangxi, China

  • The First Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • Affiliated Hospital of North China University of Technology

    Tangshan, Hebei, China

  • First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • Henan Cancer Hospital

    Zhengzhou, Henan, China

  • Union Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • Xiangyang Central Hospital

    Xiangyang, Hubei, China

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • Xiangya Hospital Central South University

    Changsha, Hunan, China

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, China

  • The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University

    Huai'an, Nanjing Province, China

  • Qinghai province people's hospital

    Xining, Qinghai, China

  • Jinan Central Hospital Affilated to Sandong University

    Jinan, Shandong, China

  • LiaoCheng People's Hospital

    Liaocheng, Shandong, China

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, China

  • Jinshan Hospital Affiliated To Fudan University

    Shanghai, Shanghai Municipality, China

  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China

  • Heping Hospital Affiliated to Changzhi Medical College

    Changzhi, Shanxi, China

  • The second hospital of Shanxi Medical University

    Taiyuan, Shanxi, China

  • Shanxi Provincial People's Hospital

    Xi’an, Shanxi, China

  • West China Hospital,Sichuan University

    Chengdu, Sichuan, China

  • The First Affilicated Hospital of Xinjiang Medical University

    Ürümqi, The Xinjiang Uygur Autonomous Region, China

  • Blood Institute of the Chinese Academy of Medical Sciences

    Tianjin, Tianjin Municipality, China

  • The second Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China

  • Zhejiang Provincial Hospital of Chinese Medicine

    Hangzhou, Zejiang Province, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.